Our study covers a broad group of patients and provides strong support that GLP-1 analogues are not associated with an increased risk of thyroid cancer. The researchers analysed national register data from Denmark, Norway, and Sweden of about 145,000 patients treated with GLP-1 analogues, mainly liraglutide or semaglutide, and 290,000 patients treated with another diabetes drug (DPP4 inhibitors)
J Eur Acad Dermatol Venereol 1999;13:205-9
Assessing OS biomarkers, including ROS levels, total antioxidant capacity (TAC), lipid peroxidation products and DNA fragmentation, is critical for detecting redox imbalances
It helps protect your cells from damage and supports your immune function
Zubrzycki A, Cierpka-Kmiec K, Kmiec Z, Wronska A (2018) The role of low-calorie diets and intermittent fasting in the treatment of obesity and type-2 diabetes